Navigation Links
Stem cells help in the understanding of drug-resistant, recurrent tumors

Massachusetts General Hospital (MGH) researchers have zeroed in on ovarian cancer stem cells that make the management of tumors all the more complex. Getting into the nuances of the stem like traits of cells will assist in developing better ways to combat ovarian cancer. //

"We feel these stem-like cancer cells may be resistant to traditional chemotherapy and could be responsible for the ultimately fatal drug-resistant recurrence that is characteristic of ovarian cancer," says Paul Szotek, MD, of the MGH Pediatric Surgical Research Laboratories, first author of the PNAS report. "We believe this likely is the first time stem-like cells have been found in models of ovarian cancer and in cells associated with human ovarian cancer."

Several recent studies have identified tiny populations of tumor cells that appear to act like stem cells, driving the tumor's ability to grow and spread. If some of these specialized cells escaped destruction by chemotherapy or radiation, the tumor would be able to recur quickly, often in a form resistant to chemotherapy. Similar cancer stem cells have been previously identified in leukemia and breast cancer and in cell lines of central nervous system and gastrointestinal tumors.

Standard treatment for ovarian cancer – surgical removal of all involved tissues followed by chemotherapy – usually appears successful, but treatment-resistant tumors recur in the vast majority of patients, leading to a five-year survival rate of less than 30 percent. Those factors and other observations suggested that cancer stem cells may also be found with ovarian tumors, leading to the current study.

The MGH researchers first examined two mouse ovarian cancer cell lines and identified cells with characteristics of the cancer stem cells found with other tumors. They then observed a small percentage of stem-like cells in human ovarian cancer lines and in cells taken from ascites fluid that had accumulated within t
'"/>




Page: 1 2

Related medicine news :

1. Action of nerve cells
2. Therapy for stopping the spread of cancer cells
3. Hydroxyurea derivatives kill colon cancer cells
4. Creating brain cells from bone marrow
5. A Chinese herb kills cancer cells
6. Immune cells halt round in space
7. Transforming stem cells to lung cells
8. Changing stem cells to liver cells
9. Enzyme stimulates growth of adult stem cells
10. Stem cells aid to cure brain cancer
11. Brain cells protected by new compounds
Post Your Comments:
(Date:9/5/2008)...RNewswire-USNewswire/ -- Speaker Nancy Pelosi,issu... aims of the "Stand,Up to Cancer" telethon, to be ...erson in our country who has not seen a loved one,...ricans annually, and each,year there are more than...gether to make eradicating the scourge of cancer a...
(Date:9/5/2008)...RNewswire-USNewswire/ -- U.S. citizens can donate,...ictims of Hurricane,Gustav, which is the worst sto...AmericanRelief.org ), "Donations will be used for... this natural disaster," says Marc Wachtenheim, Di...Pan American Development Foundation, (http://www.p...
(Date:9/5/2008)...enib helps reverse disease resistance to anti-horm...Day News) -- The drug sorafenib may help "re-sensi...l drugs, Georgetown University Medical Center res... progesterone-receptor positive (ER or PR positive...al medicines, such as aromatase inhibitors, to kee...
(Date:9/5/2008)...New York Fashion Week,s Annual Destination to Feat..., New York (PRWEB) September 5, 2008 -- http://w...tle__ American Laser], the largest provider of las...rvices in the U.S., announces sponsorship of the S...60, from Sept. 7-10, serves as the alternative Fas...
Breaking Medicine News(10 mins):Health News:Cuban Disaster Relief Donations Sought in the Wake of Hurricane Gustav 2Health News:Drug Re-Sensitizes Breast Tumors to Treatment 2Health News:American Laser Centers Sponsors STYLE360 to Share the Skinny on Body Shaping 2
...hed in Retina, it has been found that a drug, whic...ally effective// in treating cystoid macular edema... The researchers report on two patients with sever...ates for steroid therapy, the typical treatment. “...
...has been found that intake of foods during pregnan.... Scientists have found that the intake of diet// ...thers whose young children are misbehaving may hav...e of pregnancy. Dr. Laura Murray-Kolb, a postdocto...
... Trust has been fined ?100,000 after pleading guil...ollowing a routine operation//. The trust has plea...ing the operation. Sitting at Winchester Crown Co...he trust to pay ?10,000 in costs following the hea...
...Carruthers, has proposed cost cutting measures to ...He proposes to unveil his plan at a No 10 seminar ... the ?10.3 billion spent every year on drugs and t... be reduced. Fears that patients would not be give...
Other Medicine News:Health News:Hospital Trust Fined ?100,000 after Patient Deat 2
(Date:9/5/2008)...SOUTH SAN FRANCISCO, Calif., Sept. 5 /PRNewswire-F...y focused on small molecule LFA-1 inhibitors,to tr...cals, Inc. (Nasdaq:,SNSS) today announced SARcode,...l molecule LFA-1 product candidate for T-cell medi...red into a license agreement providing,SARcode wit...
(Date:9/4/2008)...PX-351 awarded orphan designation for the treatmen...Leukemia, PRINCETON, N.J., Sept. 4 /... U.S. Food & Drug Administration (FDA) has granted...unorubicin) Liposome Injection,for the treatment o...ntly preparing to conduct two randomized Phase 2,s...
(Date:9/4/2008)...Practice Bulletin for Obstetrician-Gynecologists S...tice Change-Minimally Invasive Interventional,Radi...n With Uterine,Fibroids, FAIRFAX, Va., Sept. 4 /P...onal Radiology, a national organization of nearly ...sionals dedicated to improving health,care through...
(Date:9/4/2008)... Updated Survival Data for Ipilimumab to be...FirstCall/ -- Medarex, Inc.,(Nasdaq: MEDX ) annou...umab,an investigational anti-CTLA-4 antibody, in ...tations at the 33rd Congress of the European Socie...r 12-16, 2008 in Stockholm.,Many of the following ...
Breaking Medicine Technology:SARcode and Sunesis Announce Start of Phase 1 Clinical Trial in Ocular Inflammatory Diseases 2SARcode and Sunesis Announce Start of Phase 1 Clinical Trial in Ocular Inflammatory Diseases 3Celator Pharmaceuticals Receives Orphan Drug Designation for Anticancer Agent CPX-351 2Society of Interventional Radiology Applauds Report's Uterine Fibroid Embolization Recommendations 2Society of Interventional Radiology Applauds Report's Uterine Fibroid Embolization Recommendations 3Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology 2Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology 3Is your drinking water safe 3F 13038 1UBs bioblower closer to protecting soldiers from biological attack 13035 1UBs bioblower closer to protecting soldiers from biological attack 13035 2UBs bioblower closer to protecting soldiers from biological attack 13035 3Milestone Scientific Hosts First International Computer Controlled Local Anesthetic Delivery 28CCLAD 29 Summit 13032 1Milestone Scientific Hosts First International Computer Controlled Local Anesthetic Delivery 28CCLAD 29 Summit 13032 2Milestone Scientific Hosts First International Computer Controlled Local Anesthetic Delivery 28CCLAD 29 Summit 13032 3Milestone Scientific Hosts First International Computer Controlled Local Anesthetic Delivery 28CCLAD 29 Summit 13032 4Milestone Scientific Hosts First International Computer Controlled Local Anesthetic Delivery 28CCLAD 29 Summit 13032 5Business Leaders Policy Makers and Advocates Gather to Discuss Strategies for Securing the Nations Economy by Investing in Early Childhood 13029 1Business Leaders Policy Makers and Advocates Gather to Discuss Strategies for Securing the Nations Economy by Investing in Early Childhood 13029 2Business Leaders Policy Makers and Advocates Gather to Discuss Strategies for Securing the Nations Economy by Investing in Early Childhood 13029 3
...l 2, 2007 - Medtronic, Inc.,(NYSE:MDT) today anno...linical Trial indicates that the trial has met its...IV Clinical Trial is a randomized, single-blind,tr...avor(TM) Drug,Eluting Coronary Stent as compared t...em from Boston Scientific Corporation,(NYSE:BSX). ...
...dash; The appearance of a,rash in cancer patients ...iated with longer survival, according to researche...icals, Inc. This is,not the first time that rash h...EGFR inhibitors – a class of drugs which,inc... designed to,block overproduction of the epidermal...
Other Medicine Technology:ENDEAVOR IV Clinical Trial Meets Primary Endpoint 2Skin Rash Actually Signifies Better Outcomes for Pancreatic and,Lung Cancer Patients 2Skin Rash Actually Signifies Better Outcomes for Pancreatic and,Lung Cancer Patients 3Skin Rash Actually Signifies Better Outcomes for Pancreatic and,Lung Cancer Patients 4
...Since its introduction in 1958, Bard mesh has beco...re compared. Bard mesh was used by Dr. Irving Lich..." hernia repair many years ago. Lichtenstein descr... permanent reinforcement of hernia repair. As an a...
...The Bard PerFix plug technique, recommended for th...and direct inguinal hernias, provides significant ...equiring less overall dissection and is utilized i...sult is increased patient comfort, fast rehabilita...
...The Company's Aura-i Laser System is a compact, hi...r office-based procedures. Its unique, integrated ...enign vascular, including telangiectasia on the le...ng leg veins. It can also be used as a continuous ...
...The Gemini is the newest addition to Laserscopes f... distinct wavelengths to choose from, 1064nm Nd:YA...ding non-invasive aesthetic laser market by pushin...ness while maintaining the safety and reliability ...
Medicine Products: